Lee Jennifer Kayden
SEC CIK 1801372 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | EVP, Head of North America | 75.8K | — | $16.94M | 38 | 2022-02-11 | 2026-08-13 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-14 19:04 | 2026-08-13 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $17.62 | +56.6K | 75.8K | +294% | +$997.0K |
| DT | 2026-08-14 19:04 | 2026-08-13 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $117.38 | -75.8K | 0 | -100% | -$8.90M |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | F - Tax | $108.99 | -9,237 | 19.2K | -32% | -$1.01M |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +22.6K | 28.5K | +386% | — |
| D | 2025-02-19 | 2025-02-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $57.22 | -2,035 | 5,858 | -26% | -$116.4K |
| D | 2025-02-19 | 2025-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +5,500 | 7,893 | +230% | — |
| M | 2025-02-14 | 2025-02-12+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale | $57.03 | -3,020 | 3,598 | -46% | -$172.2K |
| DM | 2025-02-11 | 2025-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $6.80 | +9,657 | 6,440 | New | +$65.7K |
| DM | 2025-02-11 | 2025-02-10+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $58.63 | -5,216 | 4,409 | -54% | -$305.8K |
| M | 2025-02-07 | 2025-02-05 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale | $60.55 | -3,066 | 1,172 | -72% | -$185.6K |
| D | 2025-02-04 | 2025-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +4,513 | 5,485 | +464% | — |
| D | 2025-02-04 | 2025-02-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $59.43 | -1,447 | 4,038 | -26% | -$86.0K |
| DM | 2024-11-13 | 2024-11-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $19.59 | +61.0K | 27.5K | New | +$1.19M |
| DM | 2024-11-13 | 2024-11-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $66.33 | -66.9K | 972 | -99% | -$4.44M |
| M | 2024-03-22 | 2024-03-20 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale | $38.77 | -18.2K | 15.9K | -53% | -$707.0K |
| 2024-03-19 | 2024-03-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale | $39.22 | -15.5K | 25.1K | -38% | -$608.5K | |
| D | 2024-02-21 | 2024-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | A - Grant | $0.00 | +33.8K | 40.6K | +493% | $0 |
| DM | 2024-02-13 | 2024-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +5,469 | 6,459 | +552% | — |
| DM | 2024-02-13 | 2024-02-12+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $50.80 | -1,638 | 7,467 | -18% | -$83.2K |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $45.06 | -1,492 | 3,021 | -33% | -$67.2K |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +4,513 | 4,513 | New | — |
| D | 2023-11-16 | 2023-11-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $6.80 | +12.0K | 13.7K | +730% | +$81.8K |
| D | 2023-11-16 | 2023-11-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $32.01 | -13.7K | 0 | -100% | -$437.8K |
| DM | 2023-11-13 | 2023-11-08+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $28.44 | -9,150 | 3,880 | -70% | -$260.3K |
| DM | 2023-11-13 | 2023-11-08+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $6.80 | +9,150 | 7,359 | New | +$62.2K |
| D | 2023-11-07 | 2023-11-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $28.00 | -80 | 1,647 | -5% | -$2,240 |
| D | 2023-11-07 | 2023-11-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $6.80 | +80 | 1,727 | +5% | +$544 |
| D | 2023-09-07 | 2023-09-05 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $6.80 | +4,519 | 7,813 | +137% | +$30.7K |
| D | 2023-09-07 | 2023-09-05 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $28.05 | -6,166 | 1,647 | -79% | -$173.0K |
| DM | 2023-08-09 | 2023-08-07+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $24.24 | -12.9K | 3,294 | -80% | -$313.7K |
| DM | 2023-08-09 | 2023-08-07+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $6.80 | +10.3K | 14.5K | +245% | +$70.1K |
| A | 2023-02-14 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | S - Sale | $27.51 | -1,204 | 3,544 | -25% | -$33.1K |
| D | 2023-02-14 | 2023-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | M - OptEx | — | +2,031 | 5,575 | +57% | — |
| D | 2023-02-14 | 2023-02-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | S - Sale+OE | $26.87 | -635 | 4,940 | -11% | -$17.1K |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | M - OptEx | — | +3,438 | 4,748 | +262% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | S - Sale+OE | $27.66 | -1,192 | 3,556 | -25% | -$33.0K |
| D | 2022-02-15 | 2022-02-15 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | S - Sale+OE | $6.10 | -722 | 1,310 | -36% | -$4,404 |
| D | 2022-02-15 | 2022-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Chien Jennifer | EVP, Head of North America | M - OptEx | — | +2,032 | 2,032 | New | — |
Purchase Sale Sale after option exercise All abbreviations